Diverse Roles and Characteristics of Academic Research Organizations in Japan: Results of A Questionnaire-Based Study

Background Clinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Academic research organizations (AROs) are non-profit entities established...

Full description

Saved in:
Bibliographic Details
Published inTherapeutic innovation & regulatory science Vol. 59; no. 5; pp. 1098 - 1106
Main Authors Tanoshima, Reo, Tanaka, Riki, Hara, Koji, Fukuoka, Hironori, Haze, Tatsuya, Inagaki, Naoko, Ijuin, Akifumi, Nitta, Manabu, Kobayashi, Yusuke, Okada, Kozo, Nozaki, Akito, Miyagi, Etsuko, Yamamoto, Tetsuya, Goto, Takahisa
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.09.2025
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN2168-4790
2168-4804
2168-4804
DOI10.1007/s43441-025-00797-9

Cover

Abstract Background Clinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Academic research organizations (AROs) are non-profit entities established to support clinician-scientists in conducting rigorous and high-quality clinical trials. However, Japan’s unique decentralized clinical trial system has resulted in relatively small AROs with diverse roles. Additionally, work style reforms among Japanese physicians pose challenges for allocating time to research. This study aimed to assess the demographics, activities, and roles of AROs in Japan. Methods We distributed a questionnaire survey to 31 AROs in Japan between October and December 2023. The survey collected data on organizational mission, vision, annual planning, clinical trial support, the number of supported studies, financial independence, and management of researchers’ working hours. Results Responses were received from 20 AROs (64.5%), including five public university hospitals and two clinical research core hospitals. The median staff size was 26.7 (range: 2–80), with public university hospitals reporting a median of 22.6 (range: 1449). Y-NEXT had a larger staff size (53.4) compared with other public university hospitals but fewer than clinical research core hospitals (median: 78.5). Thirteen AROs (65.0%) reported having organizational missions, and 25.0% were financially independent. Effort allocation for staff varied among institutions, and six AROs (30.0%) managed researchers’ working hours. Conclusion The roles and ultimate goals of AROs vary across institutions, highlighting the need for alignment with each institution’s clinical research priorities and principles.
AbstractList Clinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Academic research organizations (AROs) are non-profit entities established to support clinician-scientists in conducting rigorous and high-quality clinical trials. However, Japan's unique decentralized clinical trial system has resulted in relatively small AROs with diverse roles. Additionally, work style reforms among Japanese physicians pose challenges for allocating time to research. This study aimed to assess the demographics, activities, and roles of AROs in Japan. We distributed a questionnaire survey to 31 AROs in Japan between October and December 2023. The survey collected data on organizational mission, vision, annual planning, clinical trial support, the number of supported studies, financial independence, and management of researchers' working hours. Responses were received from 20 AROs (64.5%), including five public university hospitals and two clinical research core hospitals. The median staff size was 26.7 (range: 2-80), with public university hospitals reporting a median of 22.6 (range: 1449). Y-NEXT had a larger staff size (53.4) compared with other public university hospitals but fewer than clinical research core hospitals (median: 78.5). Thirteen AROs (65.0%) reported having organizational missions, and 25.0% were financially independent. Effort allocation for staff varied among institutions, and six AROs (30.0%) managed researchers' working hours. The roles and ultimate goals of AROs vary across institutions, highlighting the need for alignment with each institution's clinical research priorities and principles.
BackgroundClinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Academic research organizations (AROs) are non-profit entities established to support clinician-scientists in conducting rigorous and high-quality clinical trials. However, Japan’s unique decentralized clinical trial system has resulted in relatively small AROs with diverse roles. Additionally, work style reforms among Japanese physicians pose challenges for allocating time to research. This study aimed to assess the demographics, activities, and roles of AROs in Japan.MethodsWe distributed a questionnaire survey to 31 AROs in Japan between October and December 2023. The survey collected data on organizational mission, vision, annual planning, clinical trial support, the number of supported studies, financial independence, and management of researchers’ working hours.ResultsResponses were received from 20 AROs (64.5%), including five public university hospitals and two clinical research core hospitals. The median staff size was 26.7 (range: 2–80), with public university hospitals reporting a median of 22.6 (range: 1449). Y-NEXT had a larger staff size (53.4) compared with other public university hospitals but fewer than clinical research core hospitals (median: 78.5). Thirteen AROs (65.0%) reported having organizational missions, and 25.0% were financially independent. Effort allocation for staff varied among institutions, and six AROs (30.0%) managed researchers’ working hours.ConclusionThe roles and ultimate goals of AROs vary across institutions, highlighting the need for alignment with each institution’s clinical research priorities and principles.
Background Clinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Academic research organizations (AROs) are non-profit entities established to support clinician-scientists in conducting rigorous and high-quality clinical trials. However, Japan’s unique decentralized clinical trial system has resulted in relatively small AROs with diverse roles. Additionally, work style reforms among Japanese physicians pose challenges for allocating time to research. This study aimed to assess the demographics, activities, and roles of AROs in Japan. Methods We distributed a questionnaire survey to 31 AROs in Japan between October and December 2023. The survey collected data on organizational mission, vision, annual planning, clinical trial support, the number of supported studies, financial independence, and management of researchers’ working hours. Results Responses were received from 20 AROs (64.5%), including five public university hospitals and two clinical research core hospitals. The median staff size was 26.7 (range: 2–80), with public university hospitals reporting a median of 22.6 (range: 1449). Y-NEXT had a larger staff size (53.4) compared with other public university hospitals but fewer than clinical research core hospitals (median: 78.5). Thirteen AROs (65.0%) reported having organizational missions, and 25.0% were financially independent. Effort allocation for staff varied among institutions, and six AROs (30.0%) managed researchers’ working hours. Conclusion The roles and ultimate goals of AROs vary across institutions, highlighting the need for alignment with each institution’s clinical research priorities and principles.
Clinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Academic research organizations (AROs) are non-profit entities established to support clinician-scientists in conducting rigorous and high-quality clinical trials. However, Japan's unique decentralized clinical trial system has resulted in relatively small AROs with diverse roles. Additionally, work style reforms among Japanese physicians pose challenges for allocating time to research. This study aimed to assess the demographics, activities, and roles of AROs in Japan.BACKGROUNDClinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Academic research organizations (AROs) are non-profit entities established to support clinician-scientists in conducting rigorous and high-quality clinical trials. However, Japan's unique decentralized clinical trial system has resulted in relatively small AROs with diverse roles. Additionally, work style reforms among Japanese physicians pose challenges for allocating time to research. This study aimed to assess the demographics, activities, and roles of AROs in Japan.We distributed a questionnaire survey to 31 AROs in Japan between October and December 2023. The survey collected data on organizational mission, vision, annual planning, clinical trial support, the number of supported studies, financial independence, and management of researchers' working hours.METHODSWe distributed a questionnaire survey to 31 AROs in Japan between October and December 2023. The survey collected data on organizational mission, vision, annual planning, clinical trial support, the number of supported studies, financial independence, and management of researchers' working hours.Responses were received from 20 AROs (64.5%), including five public university hospitals and two clinical research core hospitals. The median staff size was 26.7 (range: 2-80), with public university hospitals reporting a median of 22.6 (range: 1449). Y-NEXT had a larger staff size (53.4) compared with other public university hospitals but fewer than clinical research core hospitals (median: 78.5). Thirteen AROs (65.0%) reported having organizational missions, and 25.0% were financially independent. Effort allocation for staff varied among institutions, and six AROs (30.0%) managed researchers' working hours.RESULTSResponses were received from 20 AROs (64.5%), including five public university hospitals and two clinical research core hospitals. The median staff size was 26.7 (range: 2-80), with public university hospitals reporting a median of 22.6 (range: 1449). Y-NEXT had a larger staff size (53.4) compared with other public university hospitals but fewer than clinical research core hospitals (median: 78.5). Thirteen AROs (65.0%) reported having organizational missions, and 25.0% were financially independent. Effort allocation for staff varied among institutions, and six AROs (30.0%) managed researchers' working hours.The roles and ultimate goals of AROs vary across institutions, highlighting the need for alignment with each institution's clinical research priorities and principles.CONCLUSIONThe roles and ultimate goals of AROs vary across institutions, highlighting the need for alignment with each institution's clinical research priorities and principles.
Author Haze, Tatsuya
Ijuin, Akifumi
Hara, Koji
Goto, Takahisa
Nozaki, Akito
Miyagi, Etsuko
Okada, Kozo
Inagaki, Naoko
Tanoshima, Reo
Tanaka, Riki
Yamamoto, Tetsuya
Fukuoka, Hironori
Kobayashi, Yusuke
Nitta, Manabu
Author_xml – sequence: 1
  givenname: Reo
  surname: Tanoshima
  fullname: Tanoshima, Reo
  email: reotano@yokohama-cu.ac.jp
  organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Department of Health Data Science, Graduate School of Data Science, Yokohama City University
– sequence: 2
  givenname: Riki
  surname: Tanaka
  fullname: Tanaka, Riki
  organization: Business Consultant, Yokohama City University Hospital
– sequence: 3
  givenname: Koji
  surname: Hara
  fullname: Hara, Koji
  organization: Graduate School of Economics and Business Administration, Yokohama City University
– sequence: 4
  givenname: Hironori
  surname: Fukuoka
  fullname: Fukuoka, Hironori
  organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Department of Gastroenterological Surgery, Yokohama City University
– sequence: 5
  givenname: Tatsuya
  surname: Haze
  fullname: Haze, Tatsuya
  organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine
– sequence: 6
  givenname: Naoko
  surname: Inagaki
  fullname: Inagaki, Naoko
  organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Department of Gastroenterology, Yokohama City University Graduate School of Medicine
– sequence: 7
  givenname: Akifumi
  surname: Ijuin
  fullname: Ijuin, Akifumi
  organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Reproduction Center, Yokohama City University Medical Center
– sequence: 8
  givenname: Manabu
  surname: Nitta
  fullname: Nitta, Manabu
  organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Department of Cardiology, Yokohama City University Graduate School of Medicine
– sequence: 9
  givenname: Yusuke
  surname: Kobayashi
  fullname: Kobayashi, Yusuke
  organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital
– sequence: 10
  givenname: Kozo
  surname: Okada
  fullname: Okada, Kozo
  organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Division of Cardiology, Yokohama City University Medical Center
– sequence: 11
  givenname: Akito
  surname: Nozaki
  fullname: Nozaki, Akito
  organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Gastroenterological Center, Yokohama City University Medical Center
– sequence: 12
  givenname: Etsuko
  surname: Miyagi
  fullname: Miyagi, Etsuko
  organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Department of Obstetrics and Gynecology, Yokohama City University Hospital
– sequence: 13
  givenname: Tetsuya
  surname: Yamamoto
  fullname: Yamamoto, Tetsuya
  organization: YCU Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Department of Neurosurgery, Yokohama City University School of Medicine
– sequence: 14
  givenname: Takahisa
  surname: Goto
  fullname: Goto, Takahisa
  organization: Department of Anesthesiology and Critical Care Medicine, Yokohama City University Graduate School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40445582$$D View this record in MEDLINE/PubMed
BookMark eNp90U1PFTEUBuDGYASRP-DCNHHjZrSfM607vKBiSIio6-bQnoGSuZ1LO0MCv95eBzBxYTdtk-dtm74vyU4aExLymrP3nLHuQ1FSKd4woZu6tV1jn5E9wVvTKMPUzuO6s2yXHJRyzeqwRnfCvCC7iimltRF7ZD6Kt5gL0vNxwEIhBbq6ggx-whzLFH2hY08PPQRcR0_PsSBkf0XP8iWkeA9THFOhMdFvsIH0cQvmYVpC9PuMZQsSxIzNJygY6I9pDnevyPMehoIHD_M--fX5-Ofqa3N69uVkdXjaeCnM1HjNgvctggBvuTFtD32rZfBMm3ChbW-5MuCRqR6DQtV55Bo7oUTQOrQo98m75dxNHm-2j3HrWDwOAyQc5-Kk4EpyZa2o9O0_9Hqcc6qvq0oLbrSUrKo3D2q-WGNwmxzXkO_c44dWIBbg81hKxv6JcOa2xbmlOFeLc3-Kc7aG5BIqFadLzH_v_k_qN99GmrA
Cites_doi 10.3389/fmed.2021.816921
ContentType Journal Article
Copyright The Author(s), under exclusive licence to The Drug Information Association, Inc 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2025. The Author(s), under exclusive licence to The Drug Information Association, Inc.
The Author(s), under exclusive licence to The Drug Information Association, Inc 2025.
Copyright_xml – notice: The Author(s), under exclusive licence to The Drug Information Association, Inc 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2025. The Author(s), under exclusive licence to The Drug Information Association, Inc.
– notice: The Author(s), under exclusive licence to The Drug Information Association, Inc 2025.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7U7
C1K
K9.
NAPCQ
7X8
DOI 10.1007/s43441-025-00797-9
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Toxicology Abstracts
Environmental Sciences and Pollution Management
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Toxicology Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest Health & Medical Complete (Alumni)

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 2168-4804
EndPage 1106
ExternalDocumentID 40445582
10_1007_s43441_025_00797_9
Genre Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GrantInformation_xml – fundername: Internal Research Funding of Yokohama City University.
GroupedDBID 01A
0R~
2JY
406
53G
7RV
7X7
88I
8AF
8AO
8FE
8FH
8FI
8FJ
8FW
8G5
AACDK
AAHNG
AAJBT
AARDL
AASML
AATNV
AAUYE
ABAKF
ABAWP
ABBRH
ABCCA
ABDBE
ABECU
ABFSG
ABFTV
ABJNI
ABKCH
ABMQK
ABRTQ
ABTEG
ABTKH
ABUWG
ACAOD
ACDTI
ACDXX
ACGFS
ACGOD
ACHSB
ACPRK
ACSTC
ACZOJ
ADBBV
ADTPH
ADYFF
AEFQL
AEMSY
AENEX
AERKM
AESKC
AEUHG
AEWDL
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFOHR
AFQWF
AFRAH
AGMZJ
AGQEE
AHMBA
AHPBZ
AHWEU
AIGIU
AILAN
AIXLP
AJZVZ
ALMA_UNASSIGNED_HOLDINGS
AMXSW
AMYLF
ARTOV
ATHPR
AUTPY
AYAKG
AYFIA
AZQEC
BBNVY
BCU
BEC
BENPR
BHPHI
BKEYQ
BKOMP
BPHCQ
BVXVI
CCPQU
DPUIP
DWQXO
EBLON
EBS
EJD
EX3
FIGPU
FNLPD
FYUFA
GNUQQ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GUQSH
H13
HCIFZ
HF~
HMCUK
HZ~
IKXTQ
IWAJR
J8X
JZLTJ
K.F
KOV
LK8
LLZTM
M2O
M2P
M2Q
M7P
NAPCQ
NPVJJ
NQJWS
O9-
P.B
PHGZM
PHGZT
PPXIY
PQGLB
PQQKQ
PROAC
PT4
PUEGO
ROL
RSV
S01
S0X
SAUOL
SCNPE
SFC
SJFOW
SJYHP
SNE
SNPRN
SOHCF
SOJ
SRMVM
SSLCW
UKHRP
WOW
ZCA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
---
29G
5GY
77I
7U7
8R4
8R5
BES
C1K
E3Z
F5P
K9.
P2P
PRG
Q2X
SJN
TAE
VQ3
7X8
ID FETCH-LOGICAL-c328t-c50dcc6ea2ac91886faf653dc058db59f9148ace04fed4e47ce15e7242d55d6e3
ISSN 2168-4790
2168-4804
IngestDate Fri Sep 05 15:57:37 EDT 2025
Thu Sep 25 00:55:49 EDT 2025
Sat Sep 20 02:12:52 EDT 2025
Thu Sep 25 00:50:45 EDT 2025
Fri Sep 19 01:10:31 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Questionnaire survey
Academic research organization
Work style reforms
Financial independence
Mission
Language English
License 2025. The Author(s), under exclusive licence to The Drug Information Association, Inc.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c328t-c50dcc6ea2ac91886faf653dc058db59f9148ace04fed4e47ce15e7242d55d6e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 40445582
PQID 3252185330
PQPubID 30058
PageCount 9
ParticipantIDs proquest_miscellaneous_3214314992
proquest_journals_3252185330
pubmed_primary_40445582
crossref_primary_10_1007_s43441_025_00797_9
springer_journals_10_1007_s43441_025_00797_9
PublicationCentury 2000
PublicationDate 20250900
PublicationDateYYYYMMDD 2025-09-01
PublicationDate_xml – month: 9
  year: 2025
  text: 20250900
PublicationDecade 2020
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: Switzerland
– name: Thousand Oaks
PublicationTitle Therapeutic innovation & regulatory science
PublicationTitleAbbrev Ther Innov Regul Sci
PublicationTitleAlternate Ther Innov Regul Sci
PublicationYear 2025
Publisher Springer International Publishing
Springer Nature B.V
Publisher_xml – name: Springer International Publishing
– name: Springer Nature B.V
References 797_CR7
797_CR8
S Saeki (797_CR10) 2024; 7
797_CR5
797_CR6
H Maeda (797_CR2) 2022; 8
797_CR3
797_CR4
797_CR1
797_CR9
References_xml – ident: 797_CR4
– ident: 797_CR3
– volume: 8
  year: 2022
  ident: 797_CR2
  publication-title: Front Med (Lausanne)
  doi: 10.3389/fmed.2021.816921
– ident: 797_CR5
– ident: 797_CR6
– ident: 797_CR1
– volume: 7
  start-page: 457
  issue: 3
  year: 2024
  ident: 797_CR10
  publication-title: JMAJ
– ident: 797_CR9
– ident: 797_CR8
– ident: 797_CR7
SSID ssj0000985728
Score 2.3237975
Snippet Background Clinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical...
Clinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical Guidelines for...
BackgroundClinical trials in Japan are governed by three regulations: Japanese Good Clinical Practice (J-GCP), the Clinical Trials Act, and the Ethical...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 1098
SubjectTerms Biological research
Biomedical Research - organization & administration
Clinical trials
Clinical Trials as Topic
Drug Safety and Pharmacovigilance
Hospitals
Humans
Japan
Medical research
Medicine
Organizations
Pharmacotherapy
Pharmacy
Questionnaires
Research centers
Research Personnel
Surveys
Surveys and Questionnaires
Working hours
Title Diverse Roles and Characteristics of Academic Research Organizations in Japan: Results of A Questionnaire-Based Study
URI https://link.springer.com/article/10.1007/s43441-025-00797-9
https://www.ncbi.nlm.nih.gov/pubmed/40445582
https://www.proquest.com/docview/3252185330
https://www.proquest.com/docview/3214314992
Volume 59
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZKJyFeEIxbYSAjob20QWliJzFv7aCaJm2aUCftLXJsRwuFZGqbh_E3-UOc2M6ll0mMl6hyThy35-vx8bki9CkcS0Y5o46s6l8SJnyHiYQ7UlJQH6SbhryyQ55fBKdX5OyaXvd6fzpRS-U6-Sx-780r-R-uwhjwtcqSfQBnm0lhAD4Df-EKHIbrP_H4qw6qUMPvVVUm7QY42aq_XOmZdQR8HWS3mX9ZGTzOYMfMTWjcqvxpojsmQ20LBZKcg1h0prDdSR12uOEInrf5WzBT3WFVA2pp2txXTny7z7ZmgrxY3WS_rOJadMb5wgxmi6wVjkuTt1b8aMZm5aIsDOlplahXLLOu_cKjTYDWpv1yywLaGuFageiNA20JNH4c1RmLTAvjWqLbGuNZ12d-azrsmpbXdqsH1SfYu42YyJEV8UFZdPSa3ZCFDms3zSaUsSn7rIljII41ccweoQMvBIWujw4ms-n0ojH9wSJoqLv-Nt_IpnPppM6dt26qTDvnoB0fvlaN5s_QU3umwRMD0Oeop_JD9PjcRm0couNLUx_9boQ7cFmN8DG-bCun371ApQU01oDGAGi8BWhcpLgGNK4BjTcAjbMca0B_wRbO-iG8B85Yw_klupp9m5-cOrYviCN8L1o7grpSiEBxjws2jqIg5WlAfSlcGsmEspTBGZ8L5ZJUSaJIKNSYqhCUURBAMlD-K9TPi1y9QZhLwXhCBFHKJzRRDB4XzE2oy5mi43SAhvVPH9-a8i_x_RwfoKOaO7EVE6vY90BDjqog7gH62NwGIV555niuirKigWPLmDDmDdBrw9XmdcQlhNII7oxqNreT37-Wtw8jf4eetH_OI9RfL0v1HtTtdfLBwvcvcnnVFg
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diverse+Roles+and+Characteristics+of+Academic+Research+Organizations+in+Japan%3A+Results+of+A+Questionnaire-Based+Study&rft.jtitle=Therapeutic+innovation+%26+regulatory+science&rft.au=Tanoshima%2C+Reo&rft.au=Tanaka%2C+Riki&rft.au=Hara%2C+Koji&rft.au=Fukuoka%2C+Hironori&rft.date=2025-09-01&rft.pub=Springer+International+Publishing&rft.issn=2168-4790&rft.eissn=2168-4804&rft.volume=59&rft.issue=5&rft.spage=1098&rft.epage=1106&rft_id=info:doi/10.1007%2Fs43441-025-00797-9&rft.externalDocID=10_1007_s43441_025_00797_9
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-4790&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-4790&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-4790&client=summon